Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Cornea. 2010 Jul;29(7):781–788. doi: 10.1097/ICO.0b013e3181cda38f

Figure 1.

Figure 1

Subjects with MGD reported global improvement in symptoms in response to 4 weeks of topical azithromycin therapy. Symptoms were assessed from a questionnaire. Subjects with MGD prior to treatment (filled bars). Subjects after 4 weeks of treatment (open bars).

*FBS= foreign body sensation